Vanguard Global Advisers’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Hold
835
– – ﹤0.01% 3508
2026
Q2
$19.9K Hold
835
– – ﹤0.01% 3333
2026
Q1
$26.1K Hold
835
– – ﹤0.01% 3241

Other funds holding ATYR

Vanguard Global Advisers's ATYR Position: Q3 2026 in Review

Vanguard Global Advisers held its aTyr Pharma (ATYR) position steady in Q3 2026 at 835 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

Vanguard Global Advisers first reported a position in ATYR in Q1 2026 and has held it in 3 quarters since. The position peaked at $26.1K in Q1 2026. 70 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Vanguard Global Advisers held 835 shares of aTyr Pharma worth $10.1K as of Q3 2026.
  • Vanguard Global Advisers left its aTyr Pharma share count unchanged in Q3 2026.
  • aTyr Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3508 holding.
  • Vanguard Global Advisers first reported a position in aTyr Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's aTyr Pharma position peaked at $26.1K in Q1 2026.
  • 70 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.